Please login to the form below

I have forgotten my password

variant

This page shows the latest variant news and features for those working in and with pharma, biotech and healthcare.

Pfizer/BioNTech’s COVID-19 vaccine is 100% effective in adolescents

weeks regarding the spread of the B.1.1.7 UK variant.

Latest news

Scribe Therapeutics continues to advance the development of its CRISPR platform and pipeline

Scribe has already engineered CRISPR enzymes found in nature into millions of novel variants, which it says have ideal therapeutic attributes to enable ‘highly effective and specific in vivo applications’.
BioNTech forecasts €9.8bn in sales of Pfizer-partnered COVID-19 vaccine in 2021

added. Pfizer and BioNTech are working on modified versions of their COVID-19 vaccine to address new variants of the SARS-CoV-2 virus. ... dose of its COVID-19 vaccine or a variant-specific vaccine, using a new construction based on the B.1.351 variant
GSK to assist in manufacturing up to 60 million doses of Novavax’s COVID-19 vaccine in the UK

Preliminary analysis also found that the UK variant was detected in over 50% of the PCR-confirmed cases, with 32 cases being caused by the UK variant, 24 by the ... Based on this information, Novavax calculated that its vaccine is 95.6% effective against
CureVac expands COVID-19 vaccine trial protocol to include variant specification

Company is aiming to ensure its vaccine efficacy data is 'meaningful' against new virus variants. ... This will allow CureVac to determine the efficacy of the vaccine candidate against select variants, the company said in a statement.
Edging towards success

The argument goes that a tiny change in, for example, colouring or speed doesn’t make enough difference in survivability for the new variant to out-compete the existing population.

More from news
Approximately 8 fully matching, plus 144 partially matching documents found.

Latest Intelligence

Back to the future

I told them it would be speciation. Evolutionary forces like the six great shifts don’t change one entity into another, they cause it to divide into variants.
AI and accelerated computing ring in new era for healthcare

Its nanopore sequencing devices have been used in more than 50 countries to sequence and track new variants of the virus that causes COVID-19, as well as for large-scale ... Through deep learning, the base calling model is able to reach an overall
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream

a cell type from thousands of potential variants.
25 Women Leaders in UK Healthcare

Building on expertise in population genomics, Ruth initiated and provides science input to AstraZeneca’s genomics initiative, which aims to analyse 2 million human genomes, identifying rare variants that underlie common
Genomics integration: can the NHS rise to the challenge?

Around 20, 000 of those letters are gene- associated and come in different variants. ... Most of these variants are harmless, but some could unlock the answer to diagnosing, and subsequently treating, those with rare diseases and cancer.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

Galenica Group strengthens management team

We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

#DemandDiversity: The science behind diversity

2) A 2018 analysis of studies looking for genetic variants associated with disease found that 78% of study participants were of European ancestry, compared with 10% of Asian ancestry and 2% ... from thousands of participants to find genetic variants
Blog - Vaccine Hesitant? It’s About What You Know and Who You Trust

the vaccines work, how safety is monitored, what new variants mean and, in the UK with at least 15m people having received at least one dose of a coronavirus vaccine (as
Travel in the time of COVID

6. Mutant variants are worrying the scientific community most at the moment.
What does the COVID-19 vaccine mean for the future of R&D?

The use of this technology should also be reassuring, should the current vaccines prove to be less effective against new COVID-19 variants, as these can be adapted rather than needing
How do companies prepare for reimbursement?

The approach also allows for the introduction of variants such as changes in competitive pricing and labelling.

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Principal Medical Writer: Varies on experience

Account Management: Competitive Salary Offered

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Content Editor - Biotechnology: Salary TBC

PMHub

Add my company

The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

Virtual congresses: video thrilled the cardio tsar: Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?: The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.: Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....